ERROR! No headcode.htm file found.


Professional Education

  • Bachelor of Science, Ohio State University (2012)
  • Doctor of Philosophy, University of Wisconsin Madison (2018)

Stanford Advisors


All Publications

  • CYTOKINE PROFILE ELEVATIONS ON ADMISSION CAN DETERMINE RISKS OF SEVERE ACUTE PANCREATITIS IN CHILDREN. The Journal of pediatrics Farrell, P. R., Jones, E. K., Hornung, L., Thompson, T., Patel, J., Lin, T. K., Nathan, J. D., Vitale, D. S., Habtezion, A., Abu-El-Haija, M. 2021


    OBJECTIVES: To utilize a Luminex platform to examine multiple cytokines simultaneously as well as clinical laboratory testing in order to identify markers that predict acute pancreatitis (AP) severity in the pediatric population on admission.STUDY DESIGN: Patients (<19 years) prospectively enrolled over a 4-year period in a single institution AP database were included in separate derivation and validation cohorts. Plasma samples were obtained within 48 hours of admission and stored for analysis. Samples from mild AP and SAP (moderately severe and severe combined) were analyzed using Luminex panels and C-Reactive Protein (CRP) testing.RESULTS: The derivation cohort examined 62 cytokines in 66 subject samples (20 control, 36 mild AP, 10 SAP) and identified interleukin 6 (IL-6) [P = .02] and monocyte chemotactic protein-1 (MCP-1) [p=0.02] as cytokines that were differentially expressed between mild and SAP. Our validation cohort analyzed 76 cytokines between 10 controls, 19 mild AP and 6 SAP subjects. IL-6 (p=0.02) and MCP-1 (p=0.007) were again found to differentiate mild AP from SAP. CRP values were obtained from 53 of the subjects, revealing a strong association between elevated CRP values and progression to severe disease (P<0.0001).CONCLUSION: This study identified and validated IL-6 and MCP-1 as predictors of SAP using 2 distinct cohorts, and showed that CRP elevation is a marker of progression to SAP. These biomarkers have not been extensively studied in the pediatric AP population. Our data allows for risk-stratification of AP patients, and represent novel insight into the immunologic response in SAP.

    View details for DOI 10.1016/j.jpeds.2021.07.015

    View details for PubMedID 34273357

  • Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California. Gut Gubatan, J. n., Levitte, S. n., Patel, A. n., Balabanis, T. n., Sharma, A. n., Jones, E. n., Lee, B. n., Manohar, M. n., Swaminathan, G. n., Park, W. n., Habtezion, A. n. 2020

    View details for DOI 10.1136/gutjnl-2020-321772

    View details for PubMedID 32493828

Stanford Medicine Resources: